XNCR Financial Statements | Balance Sheet, Income & Cash Flow Analysis
The financial statements for XNCR (XNCR) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| NKTR Nektar Therapeutics | $98.16 -2.18% |
| MNMD Mind Medicine (MindMed) Inc. | $20.69 +0.44% |
| OCS Oculis Holding AG | $27.38 -4.30% |
| ANAB AnaptysBio, Inc. | $51.82 +1.71% |
| R Ryder System, Inc. | $230.98 +0.40% |
| C Citigroup Inc. | $131.66 -1.04% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | $98.16 | -2.18% | 1.99 B | -10.09 | -9.73 | 0.00% | Buy | 1.55 |
| MNMD Mind Medicine (MindMed) Inc. | $20.69 | +0.44% | 1.56 B | -10.45 | -1.98 | 0.00% | Buy | 298 |
| OCS Oculis Holding AG | $27.38 | -4.30% | 1.57 B | -11.31 | -2.42 | 0.00% | Buy | 1.08 |
| ANAB AnaptysBio, Inc. | $51.82 | +1.71% | 1.49 B | -112.65 | -0.46 | 0.00% | Buy | 618 |
| R Ryder System, Inc. | $230.98 | +0.40% | 9.11 B | 19.26 | 11.99 | 0.79% | Buy | 323 |
| C Citigroup Inc. | $131.66 | -1.04% | 230.32 B | 16.30 | 8.08 | 0.91% | Buy | 8.05 |
Frequently Asked Questions
What are XNCR's latest financial results?
Review XNCR's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has XNCR's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is XNCR's cash flow situation and liquidity?
Cash flow statements reveal how XNCR generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does XNCR's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether XNCR is outperforming or lagging within its sector.
Are XNCR's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether XNCR's profits are repeatable and supported by strong fundamentals.